Valuation: Compugen Ltd.

Market Cap 22Cr 19Cr 18Cr 17Cr 31Cr 2.14TCr 32Cr 216.24Cr 84Cr 1.05TCr 83Cr 81Cr 3.63TCr P/E 2026 *
-8.07x
P/E 2027 * -8.18x
Enterprise Value 22Cr 19Cr 18Cr 17Cr 31Cr 2.14TCr 32Cr 216.24Cr 84Cr 1.05TCr 83Cr 81Cr 3.63TCr EV / Sales 2026 *
23.5x
EV / Sales 2027 * 13.8x
Free-Float
97.92%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Compugen Ltd.

1 day-3.31%
1 week+0.43%
Current month+9.35%
1 month+15.84%
3 months-19.86%
6 months+11.96%
Current year+52.94%
1 week 2.32
Extreme 2.32
2.52
1 month 2.01
Extreme 2.01
2.56
Current year 1.51
Extreme 1.51
3.24
1 year 1.3
Extreme 1.295
3.24
3 years 0.53
Extreme 0.53
3.24
5 years 0.51
Extreme 0.51
7.48
10 years 0.51
Extreme 0.51
19.9
Manager TitleAgeSince
Chief Executive Officer - 23/09/2025
Director of Finance/CFO 42 15/08/2024
Chief Operating Officer 49 01/01/2024
Director TitleAgeSince
Chairman 59 23/09/2025
Director/Board Member 59 11/06/2018
Director/Board Member 70 11/06/2018
Date Insider Type Main position Quantity % Market Cap.
09/07/26 Fiscal year

Chief Technology Officer

5,625 0.0059%
24/04/26 Fiscal year

Chief Executive Officer

15,000 0.0159%
24/04/26 Fiscal year

Chief Technology Officer

6,000 0.0063%
Change 5-day change 1-year change 3-year change Capi.($)
-3.31%+0.43%+49.04%+96.64% 22Cr
+1.11%-3.52%-3.28%+12.83% 4.63TCr
+3.13%+5.34%+402.93%+605.08% 4.01TCr
+2.14%+2.95%+10.83%+65.45% 3.63TCr
+4.43%-1.51%+6.73%-9.17% 3.46TCr
+1.23%-2.05%+0.56%+30.76% 2.68TCr
+0.29%-2.75% - - 1.67TCr
+14.71%+12.62%+38.50%+146.99% 1.69TCr
+0.85%-5.12%+1.18%+8.95% 1.31TCr
+1.82%+0.19%+1.45%-30.74% 1.3TCr
Average +2.52%+0.46%+56.44%+102.98% 2.44TCr
Weighted average by Cap. +2.81%+0.23%+76.31%+131.84%

Financials

2026 *2027 *
Net sales 94.14L 82.8L 76.92L 70.75L 1.33Cr 91Cr 1.35Cr 9.2Cr 3.59Cr 44Cr 3.53Cr 3.46Cr 154.28Cr 1.6Cr 1.41Cr 1.31Cr 1.21Cr 2.26Cr 155.41Cr 2.3Cr 16Cr 6.12Cr 76Cr 6.02Cr 5.89Cr 262.98Cr
Net income -2.76Cr -2.43Cr -2.25Cr -2.07Cr -3.89Cr -267.24Cr -3.96Cr -27Cr -11Cr -130.35Cr -10Cr -10Cr -452.22Cr -2.8Cr -2.46Cr -2.29Cr -2.1Cr -3.95Cr -271.27Cr -4.02Cr -27Cr -11Cr -132.31Cr -11Cr -10Cr -459.04Cr
Net Debt - -
Logo Compugen Ltd.
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.
Employees
75
Date Price Change Volume
23/26/23 $2.340 -3.31% 1,74,536
22/26/22 $2.420 -2.81% 1,84,414
21/26/21 $2.490 +6.41% 2,55,327
20/26/20 $2.340 -1.27% 2,62,650
17/26/17 $2.370 +1.72% 1,54,849
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.340USD
Average target price
4.600USD
Spread / Average Target
+96.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CGEN Stock